PMC:7103735 / 41205-41775
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T379 | 39-47 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T380 | 39-43 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T381 | 173-181 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T382 | 173-177 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T383 | 228-236 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T384 | 228-232 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T385 | 341-349 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T386 | 341-345 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T387 | 426-434 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T388 | 426-430 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T389 | 457-465 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T390 | 457-461 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T463 | 129-134 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T464 | 302-312 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signalling |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T142 | 72-81 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T143 | 292-301 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T144 | 497-506 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T69 | 302-312 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signalling |
| T70 | 527-544 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T71 | 527-544 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T342 | 0-182 | Sentence | denotes | Although the exact mechanisms by which SARS-CoV-2 might counteract host antiviral defence remain to be elucidated, this emerging virus is thought to be less pathogenic than SARS-CoV. |
| T343 | 183-383 | Sentence | denotes | Our prediction is that the IFN antagonism of SARS-CoV-2 and its ability to suppress other pathways of innate antiviral signalling might fall between those of SARS-CoV and the community-acquired HCoVs. |
| T344 | 384-570 | Sentence | denotes | Plausibly, the weakened IFN antagonism of SARS-CoV-2 compared to that of SARS-CoV might lead to more robust host antiviral defence, attenuated viral replication, and lower pathogenicity. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1184 | 210-213 | Gene | denotes | IFN | Gene:3439 |
| 1185 | 408-411 | Gene | denotes | IFN | Gene:3439 |
| 1186 | 39-49 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1187 | 173-181 | Species | denotes | SARS-CoV | Tax:694009 |
| 1188 | 228-238 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1189 | 341-349 | Species | denotes | SARS-CoV | Tax:694009 |
| 1190 | 426-436 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1191 | 457-465 | Species | denotes | SARS-CoV | Tax:694009 |